List view / Grid view

Ben Challis (AstraZeneca)

 

article

Drug Formulation In-Depth Focus 2022

Features in this in-depth focus highlight developments in the MRI…

19 April 2022 | By

Features in this in-depth focus highlight developments in the MRI contrast agent space, explore the development of precision medicine for chronic diseases and explain why immunotherapies should engage the innate immune system in the fight against cancer.